Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3

Aimée R. Kreimer, Hormuzd A. Katki, Mark Schiffman, Cosette M. Wheeler, Philip E. Castle

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background: Persistent infection with carcinogenic human papillomavirus (HPV) causes cervical precancer (cervical intraepithelial neoplasia grade 2+) which, in the United States, is commonly treated using the loop electrical excision procedure (LEEP). Data from Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion Triage Study were used to evaluate HPV persistence and reappearance after LEEP. Methods: Cervical specimens, collected before LEEP and at 6-month study visits, were tested by L1-PCR for detection of ≥27 HPV types. HPV persistence, defined as the same HPV type being present before and 6 months after LEEP, was evaluated by: (a) genotype, (b) carcinogenicity, and (c) phylogenetic species. HPV infections that cleared post-LEEP (the complement of persistence) were followed for reappearance of the same type. Results: HPV infections (n = 1,130) were detected among 481 women who underwent LEEP. Overall, 20.4% [95% confidence interval (95% CI), 18.2-22.9%) of infections persisted. Assessment of heterogeneity within the three categorizations of HPV showed that phylogenetic species best fit the data. Persistence was significantly greater by HPV types in the α3 species [all are noncarcinogenic; 40.9% (95% CI, 31.8-50.4%)] compared with HPV types in the α9 (HPV16 and related types) and α7 species (HPV18 and related types; 17.6% and 17.9%, respectively; P < 0.001 for both). HPV reappeared in 7.8% (95% CI, 6.1-9.9%) of infections that cleared after LEEP. Infections in the α3 species (22.6%) were the most likely to reappear compared with HPV types in the α9 (7.5%) and α7 (6.8%) species. Conclusions: Patterns of HPV persistence and reappearance following LEEP were better explained by phylogenetic rather than standard classifications. HPV types likely to persist after LEEP as well as those likely to repopulate the cervical/vaginal epithelium were those in the α3 species, which are in effect not treated, but are not associated with cervical cancer and are unlikely to cause disease.

Original languageEnglish (US)
Pages (from-to)11-16
Number of pages6
JournalCancer Epidemiology Biomarkers and Prevention
Volume16
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Cervical Intraepithelial Neoplasia
Therapeutics
Papillomavirus Infections
Confidence Intervals
Infection
Triage
Uterine Cervical Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3. / Kreimer, Aimée R.; Katki, Hormuzd A.; Schiffman, Mark; Wheeler, Cosette M.; Castle, Philip E.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 16, No. 1, 01.2007, p. 11-16.

Research output: Contribution to journalArticle

@article{0d4eb5d602b143758b65a32bb1f804f7,
title = "Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3",
abstract = "Background: Persistent infection with carcinogenic human papillomavirus (HPV) causes cervical precancer (cervical intraepithelial neoplasia grade 2+) which, in the United States, is commonly treated using the loop electrical excision procedure (LEEP). Data from Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion Triage Study were used to evaluate HPV persistence and reappearance after LEEP. Methods: Cervical specimens, collected before LEEP and at 6-month study visits, were tested by L1-PCR for detection of ≥27 HPV types. HPV persistence, defined as the same HPV type being present before and 6 months after LEEP, was evaluated by: (a) genotype, (b) carcinogenicity, and (c) phylogenetic species. HPV infections that cleared post-LEEP (the complement of persistence) were followed for reappearance of the same type. Results: HPV infections (n = 1,130) were detected among 481 women who underwent LEEP. Overall, 20.4{\%} [95{\%} confidence interval (95{\%} CI), 18.2-22.9{\%}) of infections persisted. Assessment of heterogeneity within the three categorizations of HPV showed that phylogenetic species best fit the data. Persistence was significantly greater by HPV types in the α3 species [all are noncarcinogenic; 40.9{\%} (95{\%} CI, 31.8-50.4{\%})] compared with HPV types in the α9 (HPV16 and related types) and α7 species (HPV18 and related types; 17.6{\%} and 17.9{\%}, respectively; P < 0.001 for both). HPV reappeared in 7.8{\%} (95{\%} CI, 6.1-9.9{\%}) of infections that cleared after LEEP. Infections in the α3 species (22.6{\%}) were the most likely to reappear compared with HPV types in the α9 (7.5{\%}) and α7 (6.8{\%}) species. Conclusions: Patterns of HPV persistence and reappearance following LEEP were better explained by phylogenetic rather than standard classifications. HPV types likely to persist after LEEP as well as those likely to repopulate the cervical/vaginal epithelium were those in the α3 species, which are in effect not treated, but are not associated with cervical cancer and are unlikely to cause disease.",
author = "Kreimer, {Aim{\'e}e R.} and Katki, {Hormuzd A.} and Mark Schiffman and Wheeler, {Cosette M.} and Castle, {Philip E.}",
year = "2007",
month = "1",
doi = "10.1158/1055-9965.EPI-06-0710",
language = "English (US)",
volume = "16",
pages = "11--16",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3

AU - Kreimer, Aimée R.

AU - Katki, Hormuzd A.

AU - Schiffman, Mark

AU - Wheeler, Cosette M.

AU - Castle, Philip E.

PY - 2007/1

Y1 - 2007/1

N2 - Background: Persistent infection with carcinogenic human papillomavirus (HPV) causes cervical precancer (cervical intraepithelial neoplasia grade 2+) which, in the United States, is commonly treated using the loop electrical excision procedure (LEEP). Data from Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion Triage Study were used to evaluate HPV persistence and reappearance after LEEP. Methods: Cervical specimens, collected before LEEP and at 6-month study visits, were tested by L1-PCR for detection of ≥27 HPV types. HPV persistence, defined as the same HPV type being present before and 6 months after LEEP, was evaluated by: (a) genotype, (b) carcinogenicity, and (c) phylogenetic species. HPV infections that cleared post-LEEP (the complement of persistence) were followed for reappearance of the same type. Results: HPV infections (n = 1,130) were detected among 481 women who underwent LEEP. Overall, 20.4% [95% confidence interval (95% CI), 18.2-22.9%) of infections persisted. Assessment of heterogeneity within the three categorizations of HPV showed that phylogenetic species best fit the data. Persistence was significantly greater by HPV types in the α3 species [all are noncarcinogenic; 40.9% (95% CI, 31.8-50.4%)] compared with HPV types in the α9 (HPV16 and related types) and α7 species (HPV18 and related types; 17.6% and 17.9%, respectively; P < 0.001 for both). HPV reappeared in 7.8% (95% CI, 6.1-9.9%) of infections that cleared after LEEP. Infections in the α3 species (22.6%) were the most likely to reappear compared with HPV types in the α9 (7.5%) and α7 (6.8%) species. Conclusions: Patterns of HPV persistence and reappearance following LEEP were better explained by phylogenetic rather than standard classifications. HPV types likely to persist after LEEP as well as those likely to repopulate the cervical/vaginal epithelium were those in the α3 species, which are in effect not treated, but are not associated with cervical cancer and are unlikely to cause disease.

AB - Background: Persistent infection with carcinogenic human papillomavirus (HPV) causes cervical precancer (cervical intraepithelial neoplasia grade 2+) which, in the United States, is commonly treated using the loop electrical excision procedure (LEEP). Data from Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion Triage Study were used to evaluate HPV persistence and reappearance after LEEP. Methods: Cervical specimens, collected before LEEP and at 6-month study visits, were tested by L1-PCR for detection of ≥27 HPV types. HPV persistence, defined as the same HPV type being present before and 6 months after LEEP, was evaluated by: (a) genotype, (b) carcinogenicity, and (c) phylogenetic species. HPV infections that cleared post-LEEP (the complement of persistence) were followed for reappearance of the same type. Results: HPV infections (n = 1,130) were detected among 481 women who underwent LEEP. Overall, 20.4% [95% confidence interval (95% CI), 18.2-22.9%) of infections persisted. Assessment of heterogeneity within the three categorizations of HPV showed that phylogenetic species best fit the data. Persistence was significantly greater by HPV types in the α3 species [all are noncarcinogenic; 40.9% (95% CI, 31.8-50.4%)] compared with HPV types in the α9 (HPV16 and related types) and α7 species (HPV18 and related types; 17.6% and 17.9%, respectively; P < 0.001 for both). HPV reappeared in 7.8% (95% CI, 6.1-9.9%) of infections that cleared after LEEP. Infections in the α3 species (22.6%) were the most likely to reappear compared with HPV types in the α9 (7.5%) and α7 (6.8%) species. Conclusions: Patterns of HPV persistence and reappearance following LEEP were better explained by phylogenetic rather than standard classifications. HPV types likely to persist after LEEP as well as those likely to repopulate the cervical/vaginal epithelium were those in the α3 species, which are in effect not treated, but are not associated with cervical cancer and are unlikely to cause disease.

UR - http://www.scopus.com/inward/record.url?scp=33846567640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846567640&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-06-0710

DO - 10.1158/1055-9965.EPI-06-0710

M3 - Article

C2 - 17220326

AN - SCOPUS:33846567640

VL - 16

SP - 11

EP - 16

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -